Journal articleMol Oncol2024
Plasminogen deficiency suppresses pancreatic ductal adenocarcinoma disease progression.
- Journal
- Mol Oncol
- Published
- 27 November 2023
- Citations
- 12
- Type
- Article
- License
- cc by
- Full text
- Open access, reuse-licensed (cc by)
These are bibliographic fields. A study card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Its licensed text is not loaded here yet, so most questions will be declined.
Try
Grants 7
- Cancer Prevention and Control P30CA082709↗
- Exploiting the Ref-1 node in pancreatic cancer: tailoring new pancreatic cancer therapy using multi-targeted combinatio… R01CA167291↗
- Thrombin-dependent mechanisms of pancreatic ductal adenocarcinoma disease R01CA211098↗
- Investigation of novel signaling protein in 3D and in vivo PDAC models using second generation Ref-1 inhibitors R01CA254110↗
- A Fragment-Based Strategy for K-RAS Covalent Inhibitors R01CA264471↗
- Reprogramming PDAC Stroma by Targeting Coagulation in the Tumor Microenvironment U01CA274304↗
- Targeting the Plasminogen Activation System to Limit Pancreatic Cancer Progression and Associated Thrombosis U01HL143403↗